Academic Journal of Medicine & Health Sciences, 2023, 4(6); doi: 10.25236/AJMHS.2023.040604.
Wang Qianfeng1, Cui Xiang2
1Department of Hepatology, The First Clinical Medical College of Shaanxi University of Chinese Medicine, Xianyang, 712406, China
2Department of Hepatology, Ankang Hospital of Traditional Chinese Medicine and Seventh Clinical Medical College of Shaanxi University of Chinese Medicine, Ankang, 725000, China
The theory of the Tibetan elephant plays an extremely important role in traditional Chinese medicine, and it explains the physiopathology of diseases under the theory of Yin and Yang and the five elements. Under the guidance of Tibetan elephant theory, this paper discusses the relationship between liver and heart, spleen, lung, kidney in detail, and expounds the connection between NAFLD and NAFLD, so as to play the advantages of TCM Tibetan elephant theory, provide ideas for the treatment of NAFLD and related diseases, and provide references for patients' diet and living habits.
theory of visceral outward manifestation; nonalcoholic fatty liver disease; related diseases; five elements
Wang Qianfeng, Cui Xiang. Non-Alcoholic Fatty Liver Disease and Related Diseases from the Theory of Visceral Outward Manifestation. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 6: 22-27. https://doi.org/10.25236/AJMHS.2023.040604.
[1] Cui Xiang, Sheng Guoguang, Xing Yufeng, et al. Effect and mechanism of prevention and treatment in rats with non-alcoholic steatohepatitis [J]. Chinese Journal of Traditional Chinese Medicine, 2021, 36 (05): 2555-2559.
[2] Zeng Shenglan, Wang Na, Zhang Rongzhen, Wang Tingshuai, Mao Dewen. Progress in the treatment of metabolic-related fatty liver disease [J]. Journal of Integrated Chinese and Western Medicine, 2022, 32 (03): 285-288.
[3] Zhu Luying, Li Yuchen, Deng Lihua, Wang Jingtong. Progress in extrahepatic disease associated with non-alcoholic fatty liver disease [J]. Journal of Clinical Hepatobiliary Diseases, 2021, 37 (09): 2215-2219.
[4] Cui Xiang, Liu Linglan, Hua Peng, et al. Experience and research overview of the treatment of non-alcoholic fatty liver disease from the spleen [J]. Clinical study of TCM, 2020, 12 (14): 136-138.
[5] Zhang Shengsheng, Li Junxiang. Consensus opinion among experts on TCM diagnosis and treatment of non-alcoholic fatty liver disease (2017) [J]. Journal of Traditional Chinese Medicine, 2017, 58 (19): 1706-1710.
[6] Huang Haipeng, Chang Junqi, Yang Tong, Xue Fuyu, Zhong Zhen, Ma Shiqi, Wang Hongfeng. Clinical progression of needle treatment for non-alcoholic fatty liver disease [J]. Jilin Traditional Chinese Medicine, 2021, 41 (11): 1527-1531.
[7] Sun Guangren, Zheng Hongxin. Basic theory of TCM [M]. China Traditional Chinese Medicine Press, 2012.
[8] Guo Wenqian, Wang Qi, Guo Gang, Ma Han, Wan Jinyi, Yao Haiqiang. Based on the human intestinal flora, the study of "spleen is the acquired foundation" [J]. Chinese Journal of Traditional Chinese Medicine, 2021, 36 (09): 5165-5168.
[9] Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy [J]. J Hepatol. 2020; 72(3):558-577.
[10] An L, Wirth U, Koch D. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases [J]. J Gastrointest Surg. 2021 Nov 3.
[11] Sharma SP, Suk KT, Kim DJ. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases [J]. World J Gastroenterol. 2021 Oct 7; 27(37):6161-6179.
[12] Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement [J]. J Hepatol. 2020; 73(1):202-209.
[13] Saraya S, Saraya M, Mahmoud M, et al. The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography [J]. Egypt Heart J. 2021 Oct 30; 73(1):96.
[14] Cai X, Zheng S, Liu Y, et al. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation [J]. Liver Int. 2020 Jul;40(7):1594-1600.
[15] Li Jinxia. Danshen bolus combined with lamiidine for chronic hepatitis B, hepatitis B cirrhosis and hepatocardiac syndrome [J]. Journal of Cardiovascular and cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2009, 7 (08): 1004-1005.
[16] Zhu Aoxiang, Chen Shengduo. Professor Zhang Chizhi's experience in the treatment of non-alcoholic fatty liver disease [J]. Journal of Integrated Chinese and Western Medicine, 2020, 30 (01): 74-75.
[17] Ding Jian, Zhu Shuyang. Analysis of the clinical characteristics of chronic obstructive pulmonary disease associated with non-alcoholic fatty liver disease [J]. Medical Review, 2019, 25 (02): 412-416.
[18] Song JU, Jang Y, Lim SY, et al. Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study [J]. PLoS One. 2019 Jan 23; 14(1):e0208736.
[19] Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management [J]. Lipids Health Dis. 2021 Oct 3; 20(1):126.
[20] Tao Z, Li Y, Cheng B, Zhou T, Gao Y. Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease [J]. J Clin Transl Hepatol. 2022; 10(1):164-173.
[21] Sinn DH, Kang D, Jang HR, et al. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study [J]. J Hepatol. 2017; 67(6):1274-1280.
[22] Park H, Dawwas GK, Liu X, Nguyen MH. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study [J]. J Intern Med. 2019; 286(6):711-722.
[23] Loosen SH, Roderburg C, Demir M, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures [J]. Z Gastroenterol. 2021 Oct 28. English.
[24] Zhang Shengsheng, Li Junxiang. Consensus opinion among experts on TCM diagnosis and treatment of non-alcoholic fatty liver disease (2017) [J]. Journal of Clinical Hepatobiliary Diseases, 2017, (12): 2270-2274.